Pharma Giant Building $2 Billion Atlanta-Area Facility

Global biopharmaceutical giant UCB, Inc. is planning a $2 billion investment in Georgia to establish its first U.S. pharmaceutical biologics manufacturing facility. Based in Belgium, UCB’s North American headquarters are located in Smyrna. UCB’s expertise is in neurology and immunology. UCB’s new 460,000-square-foot manufacturing campus will be located in Rowen, serving as an anchor tenant...